Literature DB >> 11697995

Assessment of sweat-testing practices for the diagnosis of cystic fibrosis.

V A LeGrys1.   

Abstract

OBJECTIVE: To describe the results of the College of American Pathologists survey questions assessing the current practice of sweat testing in North America and to identify areas in which improvement is needed. DATA SOURCE: Results of the supplemental questions to the SW-B 2000 survey. STUDY SELECTION: Supplemental questions were designed to assess variation in sweat collection, analysis, and interpretation. DATA EXTRACTION: Extractions of the data were made based on the relevance of the data to the objectives of the review. DATA SYNTHESIS: The majority of laboratories surveyed performed sweat testing according to the procedures described in the National Committee for Clinical Laboratory Standards' document. The study revealed that a number of laboratories have adopted poor practice standards and are potentially compromising patient care. Areas of concern include the number of laboratories performing few sweat tests per year, the persistence of unreliable methodology, misunderstanding of collection parameters, lack of patient education, and erroneous result reporting.
CONCLUSIONS: The study identified areas of concern toward which educational efforts can be directed. Such efforts include the development of a College of American Pathologists accreditation checklist for sweat testing and targeted responses in the sweat analysis participant summary report.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697995     DOI: 10.5858/2001-125-1420-AOSTPF

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Proposal of a CT scoring system of the paranasal sinuses in diagnosing cystic fibrosis.

Authors:  H B Eggesbø; S Søvik; S Dølvik; K Eiklid; F Kolmannskog
Journal:  Eur Radiol       Date:  2003-04-05       Impact factor: 5.315

Review 2.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

3.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

4.  Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening.

Authors:  Michael J Rock; Hara Levy; Christina Zaleski; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2011-08-24

5.  Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening.

Authors:  Annette Vernooij-van Langen; Edward Dompeling; Jan-Bart Yntema; Bert Arets; Harm Tiddens; Gerard Loeber; Jeannette Dankert-Roelse
Journal:  Eur J Pediatr       Date:  2015-02-13       Impact factor: 3.183

Review 6.  Patterns of gastrointestinal disease associated with mutations of CFTR.

Authors:  Michael Wilschanski
Journal:  Curr Gastroenterol Rep       Date:  2008-06

7.  Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases.

Authors:  Sophie Collardeau-Frachon; Raymonde Bouvier; Catherine Le Gall; Christine Rivet; Faiza Cabet; Gabriel Bellon; Alain Lachaux; Jean-Yves Scoazec
Journal:  Virchows Arch       Date:  2007-06-07       Impact factor: 4.064

8.  Sweat test and cystic fibrosis: overview of test performance at public and private centers in the state of São Paulo, Brazil.

Authors:  Maria Fátima Servidoni; Carla Cristina Souza Gomez; Fernando Augusto Lima Marson; Adyléia Aparecida Dalbo Contrera Toro; Maria Ângela Gonçalves de Oliveira Ribeiro; José Dirceu Ribeiro; Antônio Fernando Ribeiro
Journal:  J Bras Pneumol       Date:  2017 Mar-Apr       Impact factor: 2.624

9.  Citrate-based fluorescent materials for low-cost chloride sensing in the diagnosis of Cystic Fibrosis.

Authors:  Jimin P Kim; Zhiwei Xie; Michael Creer; Zhiwen Liu; Jian Yang
Journal:  Chem Sci       Date:  2016-08-30       Impact factor: 9.825

10.  Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.

Authors:  Frank J Accurso; Fredrick Van Goor; Jiuhong Zha; Anne J Stone; Qunming Dong; Claudia L Ordonez; Steven M Rowe; John Paul Clancy; Michael W Konstan; Heather E Hoch; Sonya L Heltshe; Bonnie W Ramsey; Preston W Campbell; Melissa A Ashlock
Journal:  J Cyst Fibros       Date:  2014-03       Impact factor: 5.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.